Show simple item record

dc.contributor.authorTOPUZ, E
dc.contributor.authorTAS, Faruk
dc.contributor.authorAYDINER, Adnan
dc.contributor.authorYasasever, V
dc.contributor.authorAYKAN, F
dc.date.accessioned2021-03-05T13:55:06Z
dc.date.available2021-03-05T13:55:06Z
dc.date.issued2001
dc.identifier.citationTAS F., AYKAN F., AYDINER A., Yasasever V., TOPUZ E., "Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.", American journal of clinical oncology, cilt.24, ss.148-9, 2001
dc.identifier.issn0277-3732
dc.identifier.otherav_b489b6a6-9926-47e9-b3ae-caf19c943103
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/120224
dc.identifier.urihttps://doi.org/10.1097/00000421-200104000-00010
dc.description.abstractIn 35 patients with recurrent gastric cancer who had undergone curative gastrectomy, serum carcinoembryonic antigen (CEA) and CA 19-9 (carbohydrate antigen) rumor marker levels were investigated. At least one tumor marker was elevated in 24 (68.6%) patients. The levels of serum CA 19-9 and CEA markers were increased in 20 (57.1%,) and 12(34.3%) patients, respectively. This difference was not statistically significant. However, it may be important in terms of clinical practice.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleMeasurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.
dc.typeMakale
dc.relation.journalAmerican journal of clinical oncology
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume24
dc.identifier.issue2
dc.identifier.startpage148
dc.identifier.endpage9
dc.contributor.firstauthorID7463


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record